雌激素相关受体a对脑胶质瘤细胞耐受替莫唑胺的影响
2023-08-03张留弟王天笑陈海飞李群益施孝金
张留弟 王天笑 陈海飞 李群益 施孝金



摘 要 目的:探究雌激素相关受体a对脑胶质瘤细胞耐受替莫唑胺(temozolomide,TMZ)的调控作用及其机制。方法:建立耐受TMZ的胶质瘤细胞株,并构建胶质瘤裸鼠移植模型;从离体和在体层面分析特异性敲减ERRa或使用ERRα反向激动剂XCT790对耐药胶质瘤细胞增殖的影响;并结合荧光定量PCR实验检测Wnt通路相关基因的表达。结果:敲减ERRα或给予XCT790均显著抑制耐药胶质瘤细胞增殖,并抑制Wnt5a信号通路关键基因的表达,动物模型中XCT790联用TMZ可有效抑制耐受TMZ的胶质瘤细胞生长。结论:抑制ERRa功能可逆转胶质瘤细胞对替莫唑胺的耐药性,这一作用可能与抑制Wnt5a信号通路的功能密切相关。
关键词 雌激素相关受体a 胶质瘤 替莫唑胺 XCT790 Wnt5a
中图分类号:R73-3; R739.41 文献标志码:A 文章编号:1006-1533(2023)11-0051-05
引用本文 张留弟, 王天笑, 陈海飞, 等. 雌激素相关受体a对脑胶质瘤细胞耐受替莫唑胺的影响[J]. 上海医药, 2023, 44(11): 51-55.
基金项目:国家自然科学基金面上项目(81973399);国家自然科学基金青年科学基金项目(81901399);上海市卫生健康委员会科研基金项目(20184Y0194, 20204Y0445)
Effect of estrogen-related receptor α on temozolomide resistance in glioma cell
ZHANG Liudi, WANG Tianxiao, CHEN Haifei, LI Qunyi, SHI Xiaojin
(Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai 200040, China)
ABSTRACT Objective: To investigate the regulatory effect and mechanism of estrogen-related receptor a (ERRa) on temozolomide resistance in glioma cells. Methods: A temozolomide (TMZ) resistant glioma cell line and a nude mouse model of glioma orthotopic transplantation were established. The effects of specific ERRa knockdown or the use of the ERRα reverse agonist XCT790 on the proliferation of TMZ-resistant glioma cells were analyzed in vitro and in vivo. The expression of Wnt pathway-related genes was detected by fluorescence quantitative PCR. Results: Knocking down ERRa or administration of XCT790 could significantly inhibit the proliferation of TMZ-resistant glioma cells and the expression of the key genes in Wnt5a signaling pathway, and prolong the survival period of model animals. Conclusion: Inhibition of ERRa function can reverse TMZ resistance in glioma cells, which may be closely related to inhibiting the function of Wnt5a signaling pathway.
KEY WORDS estrogen related receptors a; glioma; temozolomide; XCT790; Wnt5a
腦胶质瘤是成年人颅内最常见、恶性程度最高及预后情况最差的肿瘤[1]。其中胶质母细胞瘤(glioblastoma, GBM, WHO Ⅳ级)是恶性程度最高的脑胶质瘤,发病率约为3.2/10万,在所有胶质瘤患者中占46.1%[2]。目前治疗方案以手术切除为主。但由于胶质瘤细胞生长迅速,侵袭能力强,与正常脑组织无明显界限,且瘤体分布较为分散,手术很难彻底清除肿瘤病灶,因此术后须结合放化疗。在临床化疗用药中,替莫唑胺(temozolomide, TMZ)的应用最为广泛。……
